Trinity Launches InsightsEDGE Free Trial at PMSA 2026 in New Orleans

Trinity Offers Free Trial of InsightsEDGE at PMSA 2026

Trinity, a leader in life sciences commercialization, has made a significant announcement by offering a free trial of its groundbreaking platform, InsightsEDGE, during the Pharmaceutical Management Science Association (PMSA) 2026 Annual Conference held from May 3 to 6 at the Hyatt Regency in New Orleans. This initiative aligns with Trinity's role as a Diamond Sponsor at the event.

The free trial is tailored for qualified organizations within the life sciences sector that are assessing integrated launch tracking, AI-driven insight generation, and commercialization solutions powered by technology. Attendees at PMSA 2026 are encouraged to visit Trinity's booth to discover how InsightsEDGE facilitates connecting and acting upon insights derived from a diverse range of data sources, including primary, secondary, and real-world data. Participants will also gain insight into how Trinity's combined capabilities in research, analytics, and technology can enhance decision-making related to launches and commercialization strategies.

The advantages of the free trial are immense, granting organizations a practical opportunity to engage with InsightsEDGE directly. This allows them to evaluate how Trinity’s AI-enabled platform can assist in making faster, more informed decisions critical to their operations. Jonathan Jenkins, the Head of Digital and AI Solutions at Trinity, shared, "PMSA gathers key leaders who are influencing the future landscape of analytics in the pharmaceutical and biotech industries. As organizations seek more coordinated methodologies to translating data into actionable outcomes, this trial presents a fantastic opportunity to engage with InsightsEDGE and experience, firsthand, how Trinity fortifies smarter commercial outcomes."

Trinity's active participation signifies its commitment not only to innovative solutions but also to establishing collaborations that underscore the evolution of commercialization in life sciences through advanced analytics and AI-powered solutions. Jason further emphasized the connection, stating that Trinity’s presence at PMSA 2026 would be instrumental in demonstrating how their offerings leverage analytical foresight and therapeutic expertise to foster a competitive edge in the market.

The InsightsEDGE trial is an exceptional offering for those looking to enhance their capabilities in commercialization strategies. Interested organizations can connect with Trinity either by visiting their booth at the conference or accessing more information through their website at Trinity Life Sciences.

About Trinity

Established over three decades ago, Trinity has evolved from a single office in Waltham, Massachusetts, to a robust network of 1,300 professionals across 14 offices around the globe. The company focuses on merging human insights with artificial intelligence to revolutionize the commercialization process within the life sciences sector. With a robust portfolio of partnerships and a commitment to delivering clarity and confidence across every commercialization phase—from pre-launch strategies to market entry and beyond—Trinity has set new benchmarks in client partnerships, responsiveness, and quality of service. Explore more about Trinity's innovative solutions at Trinity Life Sciences.

In summary, Trinity's no-cost trial of InsightsEDGE at PMSA 2026 is an exciting opportunity for organizations within the life sciences industry to experience advanced analytics and AI-driven solutions that are reshaping the future of commercialization.